Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans
A nasal vaccine, consisting of outer membrane vesicles (OMVs) from group B Neisseria meningitidis, was given to 12 volunteers in the form of nose drops or nasal spray four times at weekly intervals, with a fifth dose 5 months later. Each nasal dose consisted of 250 μg of protein, equivalent to 10 ti...
Gespeichert in:
| Veröffentlicht in: | Infect Immun |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1998
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC108057/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9529050/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.66.4.1334-1341.1998 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
